Veracyte Financials - Benzinga

Veracyte Inc

VCYTNASDAQ

Trade with Public

Trade with Public

$46.08

0.851.88%

近くで: Sep 28, 5:00 PM EST

$46.08

0.851.88%

プレマーケット: 5:00 AM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Veracyte Financials

Veracyte (VCYT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Veracyte Raises FY2026 Sales Guidance from $582.000M-$592.000M to $590.000M-$596.000M vs $586.445M Est

Veracyte (NASDAQ:VCYT) raises FY2026 sales outlook from $582.000 million-$592.000 million to $590.000 million-$596.000 million vs $586.445 million estimate.

Benzinga Newsdesk

PRO
Veracyte Q2 Adj. EPS $0.54 Beats $0.24 Estimate, Sales $150.321M Beat $144.554M Estimate

Benzinga Newsdesk

PRO
Veracyte Raises FY2026 Sales Guidance from $570.000M-$582.000M to $582.000M-$592.000M vs $576.521M Est

Veracyte (NASDAQ:VCYT) raises FY2026 sales outlook from $570.000 million-$582.000 million to $582.000 million-$592.000 million vs $576.521 million estimate.

Benzinga Newsdesk

PRO
Veracyte Q1 Adj. EPS $0.52 Beats $0.15 Estimate, Sales $139.071M Beat $130.041M Estimate

Veracyte (NASDAQ:VCYT) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.15 by 246.67 percent. This is a 67.74 percent increase over earnings of $0.31 per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

Earnings Breakdown: Veracyte Q4

Benzinga Insights

© 2026 Benzinga | All Rights Reserved